Schizophrenia Latest Advances

Understanding Nicotine Use in Schizophrenia Through a Psychosocial Lens: A Narrative Review.

Journal: Journal of dual diagnosis

Published: September 08, 2026

Immune dysregulation in depression and psychosis: summary of current evidence and future perspectives.

Journal: The British journal of psychiatry : the journal of mental science

Published: September 08, 2026

Time to clozapine initiation in treatment-resistant schizophrenia in the United Arab Emirates: retrospective cohort study with international benchmarking.

Journal: BJPsych open

Published: September 08, 2026

A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: September 08, 2026

Circulating cell-free DNA and NETosis-related biomarkers in schizophrenia: association with clinical features and treatment.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Published: September 08, 2026

Dynamical system modeling in schizophrenia: a narrative review of computational psychiatry frameworks.

Journal: Dialogues in clinical neuroscience

Published: September 07, 2026

Mental disorders, receipt of cardiac care following myocardial infarction and the impact of the COVID-19 pandemic: a cohort study.

Journal: BMJ open

Published: September 04, 2026

Effects of a Peer Support Programme on Medication Adherence and Subjective Recovery in Individuals with Schizophrenia: A Quasi-Experimental Study.

Journal: Issues in mental health nursing

Published: September 02, 2026

Family interventions for caregivers of people with schizophrenia: a scoping review protocol.

Journal: JBI evidence synthesis

Published: September 02, 2026

Neurophysiological Evidence of Enhanced Cognitive Control Following Auditory Control Enhancement (ACE) Therapy: A Pilot RCT in Schizophrenia-Spectrum Disorders with Persistent Auditory Hallucinations.

Journal: Clinical EEG and neuroscience

Published: September 02, 2026

Evaluation of the Psychometric Scale Properties of Reflective Functioning Questionnaire (RFQ-8) in Persons with Schizophrenia Spectrum Disorders and Healthy Controls.

Journal: Journal of personality assessment

Published: September 02, 2026

A Case of Schizophrenia with Diagnostic Challenges Between Non-convulsive Status Epilepticus and Malignant Catatonia: Therapeutic Implications based on the GABA-A Dysfunction Hypothesis.

Journal: Journal of UOEH

Published: September 02, 2026

Schizophrenia Latest Advances

Find the Latest Research About Schizophrenia

Understanding Nicotine Use in Schizophrenia Through a Psychosocial Lens: A Narrative Review.

Understanding Nicotine Use in Schizophrenia Through a Psychosocial Lens: A Narrative Review.

Immune dysregulation in depression and psychosis: summary of current evidence and future perspectives.

Immune dysregulation in depression and psychosis: summary of current evidence and future perspectives.

Time to clozapine initiation in treatment-resistant schizophrenia in the United Arab Emirates: retrospective cohort study with international benchmarking.

Time to clozapine initiation in treatment-resistant schizophrenia in the United Arab Emirates: retrospective cohort study with international benchmarking.

A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement.

A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement.

Circulating cell-free DNA and NETosis-related biomarkers in schizophrenia: association with clinical features and treatment.

Circulating cell-free DNA and NETosis-related biomarkers in schizophrenia: association with clinical features and treatment.

Dynamical system modeling in schizophrenia: a narrative review of computational psychiatry frameworks.

Dynamical system modeling in schizophrenia: a narrative review of computational psychiatry frameworks.

Mental disorders, receipt of cardiac care following myocardial infarction and the impact of the COVID-19 pandemic: a cohort study.

Mental disorders, receipt of cardiac care following myocardial infarction and the impact of the COVID-19 pandemic: a cohort study.

Effects of a Peer Support Programme on Medication Adherence and Subjective Recovery in Individuals with Schizophrenia: A Quasi-Experimental Study.

Effects of a Peer Support Programme on Medication Adherence and Subjective Recovery in Individuals with Schizophrenia: A Quasi-Experimental Study.

Family interventions for caregivers of people with schizophrenia: a scoping review protocol.

Family interventions for caregivers of people with schizophrenia: a scoping review protocol.

Neurophysiological Evidence of Enhanced Cognitive Control Following Auditory Control Enhancement (ACE) Therapy: A Pilot RCT in Schizophrenia-Spectrum Disorders with Persistent Auditory Hallucinations.

Neurophysiological Evidence of Enhanced Cognitive Control Following Auditory Control Enhancement (ACE) Therapy: A Pilot RCT in Schizophrenia-Spectrum Disorders with Persistent Auditory Hallucinations.

Evaluation of the Psychometric Scale Properties of Reflective Functioning Questionnaire (RFQ-8) in Persons with Schizophrenia Spectrum Disorders and Healthy Controls.

Evaluation of the Psychometric Scale Properties of Reflective Functioning Questionnaire (RFQ-8) in Persons with Schizophrenia Spectrum Disorders and Healthy Controls.

A Case of Schizophrenia with Diagnostic Challenges Between Non-convulsive Status Epilepticus and Malignant Catatonia: Therapeutic Implications based on the GABA-A Dysfunction Hypothesis.

A Case of Schizophrenia with Diagnostic Challenges Between Non-convulsive Status Epilepticus and Malignant Catatonia: Therapeutic Implications based on the GABA-A Dysfunction Hypothesis.